CenterBook Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-81,005
Closed -$1.12M 843
2026
Q1
$1.12M Buy
+81,005
New +$1.13M 0.06% 337
2025
Q3
Sell
-42,728
Closed -$642K 645
2025
Q2
$642K Buy
42,728
+23,163
+118% +$331K 0.04% 401
2025
Q1
$258K Buy
+19,565
New +$270K 0.02% 458

Other funds holding RDY

CenterBook Partners's RDY Position: Q2 2026 in Review

CenterBook Partners sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 81,005 shares — an estimated $1.12M sold.

CenterBook Partners first reported a position in RDY in Q1 2025 and held it in 3 quarters. The position peaked at $1.12M in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • CenterBook Partners reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • CenterBook Partners sold 81,005 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $1.12M.
  • CenterBook Partners first reported a position in Dr. Reddy's Laboratories in Q1 2025 and held it in 3 quarters.
  • CenterBook Partners's Dr. Reddy's Laboratories position peaked at $1.12M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.